Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
about
Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.Urinary CE-MS peptide marker pattern for detection of solid tumors.
P2860
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Increased fibrinogen levels at ...... s with acute myeloid leukemia.
@en
Increased fibrinogen levels at ...... s with acute myeloid leukemia.
@nl
type
label
Increased fibrinogen levels at ...... s with acute myeloid leukemia.
@en
Increased fibrinogen levels at ...... s with acute myeloid leukemia.
@nl
prefLabel
Increased fibrinogen levels at ...... s with acute myeloid leukemia.
@en
Increased fibrinogen levels at ...... s with acute myeloid leukemia.
@nl
P2093
P2860
P356
P1476
Increased fibrinogen levels at ...... s with acute myeloid leukemia.
@en
P2093
Alexander D Heini
Beatrice Mueller
Martin D Berger
Thomas Pabst
P2860
P304
P356
10.1002/HON.2307
P577
2016-06-15T00:00:00Z